Literature DB >> 24785886

Analysis of recent cases of intestinal tuberculosis in Japan.

Tateki Yamane1, Akira Umeda, Hitoshi Shimao.   

Abstract

In Japan, which ranks first among developed countries in the incidence of tuberculosis, intestinal tuberculosis should be regarded as an important disease. However, few studies of this condition have recently been reported. We analyzed nine patients treated at our hospital during and after 2000. Our results differ from those of previous studies in that many of the patients were healthy, not elderly, had primary intestinal tuberculosis and presented with non-gastrointestinal symptoms. All seven patients tested were found to be whole blood interferon gamma release assay (IGRA)-positive. These results suggest that IGRA is useful as an adjunct method for diagnosing intestinal tuberculosis.

Entities:  

Mesh:

Year:  2014        PMID: 24785886     DOI: 10.2169/internalmedicine.53.1862

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Clinicopathological profile of gastrointestinal tuberculosis: a multinational ID-IRI study.

Authors:  Alpaslan Tanoglu; Hakan Erdem; Jon S Friedland; Fahad M Almajid; Ayse Batirel; Sholpan Kulzhanova; Maiya Konkayeva; Zauresh Smagulova; Filiz Pehlivanoglu; Sophia de Saram; Serda Gulsun; Fatma Amer; Ilker Inanc Balkan; Recep Tekin; Antonio Cascio; Nicolas Dauby; Fatma Sirmatel; Meltem Tasbakan; Aysegul Erdem; Ahmed Ashraf Wegdan; Ozlem Aydin; Salih Cesur; Secil Deniz; Seniha Senbayrak; Affan Denk; Tolga Duzenli; Soline Siméon; Ahsen Oncul; Burak Ozseker; Tolga Yakar; Necati Ormeci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-22       Impact factor: 3.267

2.  Differences in Clinical Manifestations according to the Positivity of Interferon-γ Assay in Patients with Intestinal Tuberculosis.

Authors:  Hye Jin Jung; Young-Ho Kim; You Sun Kim; Seong Yeon Jeong; Sung Won Park; Ji Yeon Seo; Hyemi Jung; Jong Pil Im; Ji Won Kim; Sung Noh Hong; Kuk Lae Lee
Journal:  Gut Liver       Date:  2016-07-16       Impact factor: 4.519

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.